This triple-action jab can lower your blood sugar and weight

Weekly diabetes jab shown to reduce blood-sugar levels and body weight

Retatrutide, Eli Lilly's weekly injection, reduced HbA1c 1.7-1.9 points and weight 11.5-15.3% in 930 diabetics—4× better than placebo. For health IT leaders, this signals a market shift toward multi-target biologics, reshaping pharma partnerships and healthcare data infrastructure investments.